Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum’s purification and filtration business for about $4.1 billion. The deal is expected to complement Thermo’s bioproduction business, which helps with the drug development process. The transaction is expected to be completed by the end of 2025.Read More
